Latest News

Date Title Topic
04 Jul 2013 European Medicines Agency Recommends Granting Marketing Authorisation for Sipuleucel-T Genitourinary cancers - Anticancer agents & Biologic therapy
Pancreatic Cancer
03 Jul 2013 European Medicines Agency Recommends Granting a Marketing Authorisation for Regorafenib Gastrointestinal cancers - Anticancer agents & Biologic therapy
02 Jul 2013 European Medicines Agency Recommends Granting a Marketing Authorisation for Dabrafenib Melanoma - Anticancer agents & Biologic therapy
02 Jul 2013 Pancreatic Cancer: Tackling the Tumour by Targeting its Surroundings Translational research - Gastrointestinal cancers
27 Jun 2013 Confronting the Complexity of EGFR/HER Targeted Therapies in Breast, Colorectal and Lung Cancers Personalised medicine
26 Jun 2013 A Comprehensive Genomic Mutation Profiling Analysis of Adenoid Cystic Carcinoma Pathology/Molecular biology - Translational research - Head and neck cancers
25 Jun 2013 Identifying the Drivers of Breast Cancer Breast cancer - Translational research
24 Jun 2013 A Novel Agent, Ibrutinib, Shows Potential as a Safe, Effective, Targeted Treatment Haematologic malignancies - Anticancer agents & Biologic therapy
19 Jun 2013 Just 11 Percent of Adults and 5 Percent of Children Participate in Medical Research Bioethics, legal and economic issues
18 Jun 2013 EMUC 2013 Press Release: From Guidelines to Personalised Medicine 5th EMUC Examines Personalised Therapies for Urological Cancers Genitourinary cancers
Locum Consultant, Medical Oncology, UK
17 Jun 2013 BioMarker IGF Project Aims to Identify and Validate Biomarkers for the IGF-1 Signalling Pathway in Cancer Personalised medicine - Translational research
13 Jun 2013 First-line Treatment Strategies for Advanced-Stage Follicular Lymphoma: Which is The Best One? Haematologic malignancies